Naloxone In US: ‘Over-Regulated’ And Underused
Executive Summary
“A big part of our failure to stop overdose deaths is that the medical and public health establishment cannot reach the populations at greatest risk of overdose,” says overdose prevention researcher Nabarun Dasgupta.
You may also be interested in...
Australian Pharmacists Support Providing Nonprescription Naloxone But Training Unavailable
Two studies revealed a lack of knowledge by pharmacists in Australia about providing naloxone despite being available without a prescription from pharmacists since 2016. Results could be an indication of potential problems if the opioid antagonist is made available nonprescription in US.
It’s Been Over 1100 Days Since MCIT, Still No TCET In Sight
AdvaMed’s new online clock documents the time since CMS promised to replace MCIT, a program guaranteeing coverage for FDA-cleared breakthrough devices.
NAM’S Health Care AI Development Code Of Conduct Addresses Gaps In Current Principles
The National Academy of Medicine developed a code of conduct for health care AI development, as well as commitments for code implementation.